Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 3, 2016

View Archived Issues

FDA approves blood-based companion diagnostic for Tagrisso

Cempra announces encouraging interim data from phase II trial of solithromycin in NASH

Micatrio approved in Japan for hypertension

Phase II efficacy results for ABT-436 in alcohol-dependent subjects

Safety and efficacy of durvalumab in patients with advanced urothelial bladder cancer

Combination of routine biochemical markers improves the management of patients with MDD

Bayer Pharma patents prostanoid FP antagonists

Bayer Pharma discloses coagulation factor XIa and kallikrein inhibitors

Roche describes mGlu4 receptor positive allosteric modulators

Cellectar Biosciences reports positive data on phase I trial of CLR-131

Hetero Research Foundation develops antiviral agents

Genentech and Roche present JAK1 inhibitors

Catabasis and Sarepta enter joint DMD research collaboration

EMA accepts and validates masitinib MAA for ALS

Boehringer Ingelheim and Sarah Cannon Institute enter collaboration for cancer drug development

Reducing off-target NELL-1 effects

Celgene exercises option to obtain ex-U.S. rights to Abide's ABX-1431

Bill & Melinda Gates Foundation gives grant to Sirenas

Cognition Therapeutics receives grant from Michael J. Fox Foundation for research in Parkinson's

Novel T-type calcium channel blockers show analgesic effects in vivo

Allergan licenses MEDI-2070 rights from MedImmune

FDA completes IND review for phase II study of nilotinib in patients Alzheimer's disease

Promising data from first phase III trial of Cimzia in moderate to severe chronic plaque psoriasis

Regeneron reports topline data from phase II trial of aflibercept/rinucumab in wet AMD

Glecaprevir/pibrentasvir investigational HCV regimen receives FDA breakthrough therapy designation

Truberzi approved in E.U. for IBS-D

Proveca's Sialanar approved in Europe for sialorrhea

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...